Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
Idiopathic pulmonary fibrosis (IPF) is one of the most common and devastating interstitial lung diseases with poor prognosis. Currently, few effective drugs are available for IPF. Hence, we sought to explore the role of mefunidone (MFD), a newly synthesized drug developed by our team, in lung fibros...
Saved in:
Main Authors: | Yuanyuan Han (Author), Mao Jiang (Author), Rongling He (Author), Xin Lv (Author), Xiaohua Liao (Author), Yijun He (Author), Fan Zhang (Author), Lingzhi Long (Author), Guoliang Jiang (Author), Zhangzhe Peng (Author), Lijian Tao (Author), Gaoyun Hu (Author), Jie Meng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury
by: Jiajia Li, et al.
Published: (2022) -
Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway
by: Xin Lv, et al.
Published: (2021) -
Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury
by: Jiajia Li, et al.
Published: (2023) -
A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19
by: Xiaohua Liao, et al.
Published: (2021) -
Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway
by: Qin Dai, et al.
Published: (2020)